Sir, Pseudomonas aeruginosa is a common cause of nosocomial infections. The presence of highly antibiotic-resistant strains has complicated the treatment of bacterial infections. During growth, P. aeruginosa generally encounters oxidative stress generated from the aerobic metabolism of phagocytic cells during infection and from the action of some antibiotics. 1 Genomewide screening of P. aeruginosa mutants has identified several genetic loci that alter antibiotic resistance levels. 2 Iron-sulphur clusters ([Fe-S]) are important co-factors for a number of proteins with biologically relevant functions, mostly in various redox reactions. To date, three pathways have been identified for the assembly of [Fe-S] in bacteria: Isc (iron-sulphur cluster); Suf (sulphur formation); and Nif (nitrogen fixation) systems. 3 The BLASTP algorithm (http://blast.ncbi.nlm.nih.gov), and Escherichia coli Isc and Suf, and Azotobacter vinelandii Nif as the query sequences were used to search the P. aeruginosa (PAO1) genome 4 for [Fe-S] assembly systems. This unveiled the presence of a putative isc gene cluster, comprising iscR (PA3815), iscS (PA3814), iscU (PA3813) and iscA (PA3812) encoding a transcriptional regulator, cysteine desulphurase, U-type [Fe-S] scaffold protein and A-type [Fe-S] scaffold protein, respectively, as well as a suf gene cluster, composed of sufS (PA3667, cysteine desulphurase) and sufE (PA3668,[Fe-S] scaffold protein). 3 The deduced amino acid sequences of these putative genes share .40% identity with the query sequences.
In addition to the isc and suf pathways, PAO1 also possesses an open reading frame (PA1847) homologous to nfuA. NfuA represents a novel class of [Fe-S] scaffold protein involved in the chaperone and maturation of [Fe-S] proteins, such as aconitase. 5, 6 The deduced amino acid sequence of PAO1 NfuA shares 82% and 52% identity with A. vinelandii and E. coli NfuA, respectively. PAO1 NfuA, a 194 amino acid protein, contains two functionally related domains: an A-type [Fe-S] synthesis domain at the N terminus; and a NifU-like domain for a U-type scaffold protein at the C terminus. The CXXC motif of the NifU domain, essential for the in vitro assembly of [Fe-S], 5 is conserved. A PAO1 DnfuA mutant was constructed using an allelic exchange technique, with a cre-lox for antibiotic marker recycling as previously described. 7 Briefly, the 1 kb upstream region of nfuA was PCR amplified from PAO1 genomic DNA with BT3076 (5 ′ -AGCGAACCTACTACGGGC-3 ′ ) and BT3077 (5 ′ -GAATTCGGCCAG ATACGC-3 ′ ) primers. The product, cut with EcoRI, was cloned into pBluescript KS(2) (Stratagene), yielding pKSUp. The 1 kb downstream region of nfuA amplified with BT3096 (5 ′ -AAG CTTCGGGATGGTCGA-3 ′ ) and BT3097 (5 ′ -GACTGGCGATTTCCTCTG-3 ′ ) primers was cloned into pKSUp, forming pKSUpDown. Next, the lox-flanked gentamicin resistance (Gm r ) cassette from pCM351 7 was cloned into pKSUpDown digested with EcoRV-EcoRI, generating pKSUpGmDown. The recombinant plasmid was transferred into PAO1 and the DnfuA mutant was selected from carbenicillinsusceptible (Cb s ) and Gm r phenotypes. Deletion of Gm r from the DnfuA mutant was achieved through Cre-Lox recombination, as previously described. 7 The DnfuA mutant was confirmed by PCR with two primers flanking the deletion site. The DnfuA mutant showed no growth defect in rich media.
Since proteins containing [Fe-S] have been proposed as one of the key players in the hydroxyl radical-mediated cell death induced by fluoroquinolone antibiotics, 8, 9 we tested whether DnfuA altered the level of antibiotic susceptibility. The results of the Kirby -Bauer disc diffusion assay of PAO1, the DnfuA mutant and the complemented strain (DnfuA mutant harbouring the pNfuA plasmid for ectopic expression of nfuA) illustrated that the nfuA mutant was more susceptible to fluoroquinolone antibiotics (ciprofloxacin and norfloxacin) than PAO1, as judged by wider growth inhibition zones (Figure 1 ). The enhanced susceptibility to antibiotics of the nfuA mutant was fully restored to the wild-type level by the expression of nfuA from the pNfuA plasmid (Figure 1 ). The MICs of ciprofloxacin and norfloxacin were determined using the broth dilution method with Mueller -Hinton medium. The DnfuA mutant showed reduced MICs (0.05 mg/L for ciprofloxacin and 0.5 mg/L for norfloxacin) compared with PAO1 (0.2 mg/L for ciprofloxacin and 2.0 mg/L for norfloxacin). Expression of nfuA from the pNfuA plasmid restored the reduced MIC values of the DnfuA mutant to PAO1 levels. The data confirmed that the altered susceptibility levels to ciprofloxacin and norfloxacin were due to the loss of nfuA function. Fluoroquinolone antibiotics exert their bactericidal activity by blocking the replication forks through binding DNA gyrases (topoisomerase II) and/or topoisomerase IV. 9 Recently, a new pathway has been proposed for gyrase-inhibiting antibiotics to modulate cell death via the generation of the hydroxyl radical. 1, 8 The treatment of E. coli with norfloxacin causes an increased production of superoxide anions and results in an up-regulation of genes involved in superoxide stress response, the assembly of [Fe-S] and iron homeostasis, respectively. 8, 9 Thus, gyrase inhibition by antibiotics promotes the production of superoxide anions that could attack [Fe-S] in proteins, causing a release of free ferrous ions (Fe 2+ ). Free cytoplasmic Fe 2+ then rapidly reacts with intracellular H 2 O 2 via a Fenton's reaction to generate the hydroxyl radical, which could cause cell death. 8, 9 We further investigated whether the increased susceptibility to fluoroquinolone antibiotics in the DnfuA mutant involved antibiotic-induced reactive oxygen species (ROS) by testing antibiotic susceptibility levels under microaerobic conditions. Ciprofloxacin treatment caused a 2-fold induction of nfuA expression. 10 We hypothesized that if the antibiotic killing of the bacteria involved the generation of an ROS-reduced overall oxygen level, then a condition known to reduce intracellular ROS levels should negate the phenotype. The results showed that under reduced oxygen atmospheric conditions, both the PAO1 and the DnfuA mutant displayed similar zones of growth inhibition against ciprofloxacin and norfloxacin antibiotics (Figure 1 ). The data suggest that nfuA may be involved in the oxidative stress protection pathway, which is responsible for the protection against ROS killing by fluoroquinolones, but further experimentation is required to elucidate the precise roles of NfuA. No significant changes in the drug susceptibility levels of the DnfuA mutant compared with PAO1 were observed with other antibiotic families, even in those antibiotic families (aminoglycoside and b-lactam) known to generate hydroxyl radicals, 1 suggesting that nfuA is not a part of the killing pathways of these antibiotics. . Susceptibility of P. aeruginosa strains to fluoroquinolone antibiotics. Susceptibility of the wild-type (PAO1), DnfuA mutant and complemented strain (DnfuA/pNfuA) to ciprofloxacin (CIP) and norfloxacin (NOR) was determined using the disc diffusion method. Plates were incubated in aerobic and microaerobic (5% O 2 ) atmospheres.
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